Holen Sie sich die Stockscreener-App
18.63
4.96%
0.88
Handel nachbörslich:
18.74
0.11
+0.59%
Schlusskurs vom Vortag:
$17.75
Offen:
$17.84
24-Stunden-Volumen:
277.48K
Relative Volume:
0.95
Marktkapitalisierung:
$567.16M
Einnahmen:
$290.71M
Nettoeinkommen (Verlust:
$-163.43M
KGV:
-3.3996
EPS:
-5.48
Netto-Cashflow:
$11.70M
1W Leistung:
+3.10%
1M Leistung:
-4.61%
6M Leistung:
+9.85%
1J Leistung:
-16.61%
1-Tages-Spanne:
$17.84
$18.67
1-Wochen-Bereich:
$17.50
$18.67
52-Wochen-Spanne:
$14.76
$25.11
Fulgent Genetics Inc Stock (FLGT) Company Profile
Firmenname
Fulgent Genetics Inc
Sektor
Branche
Telefon
626-350-0537
Adresse
4399 SANTA ANITA AVE, EL MONTE
Vergleichen Sie FLGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
18.63 | 550.12M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2022-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Eingeleitet | Raymond James | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-02-04 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-01-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-08-20 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-29 | Eingeleitet | BTIG Research | Buy |
| 2019-11-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
Alle ansehen
Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten
What analysts say about Fulgent Genetics Inc. stockPhenomenal capital gains - Autocar Professional
Is Fulgent Genetics Inc. a good long term investmentHigh-yield capital appreciation - Autocar Professional
What drives Fulgent Genetics Inc. stock priceDouble-digit growth - Autocar Professional
Fulgent Genetics Inc. Stock Analysis and ForecastUnmatched profit growth - PrintWeekIndia
Fulgent Genetics(FLGT) Shares Plunge 1.93% Despite Strong Q4 Growth - AInvest
Fulgent Genetics gets EU approval for germline sequencing system - MSN
Fulgent Genetics receives CE certification for NGS testing system By Investing.com - Investing.com South Africa
Fulgent Genetics receives CE certification for NGS testing system - Investing.com Australia
Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM - The Globe and Mail
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, - GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
(FLGT) Proactive Strategies - news.stocktradersdaily.com
What makes Fulgent Genetics Inc. stock price move sharplyROI Driven Alerts - Newser
Why Fulgent Genetics Inc. stock attracts strong analyst attentionFree Smart Money Group - Newser
How Fulgent Genetics Inc. stock performs during market volatilityInstant Stock Updates - Newser
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Peapod Lane Capital LLC - MarketBeat
Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025 - BioSpace
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Acquired by GAMMA Investing LLC - Defense World
iRhythm Technologies (NASDAQ:IRTC) & Fulgent Genetics (NASDAQ:FLGT) Financial Review - Defense World
(FLGT) Long Term Investment Analysis - news.stocktradersdaily.com
Rhumbline Advisers Sells 34,049 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics: A 'Sum Of The Parts' Story (NASDAQ:FLGT) - Seeking Alpha
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent - Bluefield Daily Telegraph
GAMMA Investing LLC Acquires 72,261 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent ... - Bluefield Daily Telegraph
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,986 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bragar Eagel & Squire, P.C. Is Investigating Semler, - GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages ... - Bluefield Daily Telegraph
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bank of America Corp DE Has $1.48 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):